IN VITRO FERTILIZATION

Size: px
Start display at page:

Download "IN VITRO FERTILIZATION"

Transcription

1 FERTILITY AND STERILITY VOL. 76, NO. 2, AUGUST 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION Embryo fragmentation in vitro and its impact on treatment and pregnancy outcome Thomas Ebner, Ph.D., a Cemil Yaman, M.D., a Marianne Moser, Ph.D., a Michael Sommergruber, M.D., a Werner Pölz, Ph.D., b and Gernot Tews, M.D. a Women s General Hospital, Linz, Austria Received August 30, 2000; revised and accepted April 10, No support of any kind was granted for this study. Presented in part at the 16th Annual Meeting of the European Society of Human Reproduction and Embriology (ESHRE), Bologna, Italy, June 25 28, Reprint requests: Thomas Ebner, Ph.D., Women s General Hospital, IVF-Unit, Lederergasse 47, A-4010 Linz, Austria (FAX: ; thomas. ebner@li.lkh.ooe.gv.at). a IVF-Unit, Women s General Hospital, Linz, Austria. b Department for Statistics, University of Linz, Linz, Austria /01/$20.00 PII S (01) Objective: To determine the impact of embryo fragmentation on pregnancy, obstetric, and perinatal outcome. Design: Retrospective analysis of embryo transfers that were homogeneous in regard to the degree of fragmentation. Setting: Fertility center. Patient(s): A cohort of 460 fresh embryo transfers. Intervention(s): A total of 164 pregnancies were analyzed for the incidence of antepartum complications during gestation, obstetric (multiple pregnancy, preterm delivery, cesarean section), and perinatal outcome (sex, birth weight, admission to neonatal intensive care unit, malformations). Main Outcome Measure(s): Implantation and clinical pregnancy rate, obstetric and perinatal outcome. Result(s): Embryo fragmentation and number of embryos per transfer showed a significant influence on clinical pregnancy and implantation rate. No such relation was found concerning complications, multiple pregnancy rate, incidence of cesarean section, gestation week, birth weight, and average time at the neonatology. On the other hand, pregnancies derived from bad-quality embryos had a significantly higher rate of malformations. Conclusion(s): The higher percentage of malformations found in bad-quality embryos may be due to a higher percentage of apoptotic features and chromosomal disorders. For ethical reasons, the transfer of embryos with 50% fragmentation should be considered only after consultation with the patient. (Fertil Steril 2001;76: by American Society for Reproductive Medicine.) Key Words: Embryo quality, fragmentation, implantation rate, malformation, number of embryos, pregnancy outcome It is well established that the success rate of IVF or intracytoplasmic sperm injection (ICSI) cycles is determined by uterine receptivity and by the number and quality of embryos transferred (1 3). From the beginning of assisted reproduction, embryo quality parameters have remained largely unchanged. The decision of which embryos to transfer is based on the manifestation of the blastomeres and the degree of fragmentation (4). The occurrence of embryo fragmentation in vitro is a common feature and supposed to be associated with a deleterious outcome (2, 3, 5, 6). There have been only a few reports of pregnancies after embryo transfer (ET) of heavily fragmented embryos (4, 6 9). Because most of these studies dealt with heterogeneous ETs, with regard to the degree of fragmentation (4, 7, 8), it can only be assumed which embryo implanted and which did not. Comparison between programs is difficult because evaluation systems that are not standardized are used. Alikani et al. (10) has described a very detailed embryo classification system that implies a close relationship between embryo fragmentation patterns and the incidence of implantation. This, coupled with the fact that a wide range of chromosomal abnormalities are found in fragmented embryos (11 13), led us to retrospectively search our data for homogeneous transfers, consisting exclusively of embryos with the same fragmentation, and to use this information to study the 281

2 impact of embryo fragmentation on the rates of implantation and clinical pregnancy. Because chromosomal abnormalities may harm pregnancies irreversibly or result in loss of pregnancy, we evaluated a possible relationship between embryo fragmentation and the obstetric and perinatal outcome. To date, it has been accepted that there is no difference in obstetric and perinatal outcome between IVF-ICSI and natural cycles (14, 15), for example. Differences in birth weight and preterm delivery are rather the result of multiple pregnancies. MATERIALS AND METHODS Because the present study is dealing with retrospective data of a routine process, approval of the internal institutional review board was obtained. A pool of 1,064 patients was retrospectively searched for homogeneous transfers consisting exclusively of embryos with the same degree of fragmentation (group A: no fragmentation; group B: 25% fragments; group C: 25% 50% fragments; group D: 50% fragments). During this 4-year period, the couples were referred either to the IVF (n 473) or the ICSI program (n 591). A total of 460 ETs were considered homogeneous. The mean age of all these patients was years. Patients with recurrent pregnancy loss were excluded from further analysis. Our criteria for exclusion were at least three consecutive early pregnancy losses. In addition, women suffering from corpus luteum insufficiency or showing an endometrium 8 mm were not included in our study to minimize a possible inhibiting influence on implantation. In all cycles, ovarian stimulation was performed using a long protocol (16) combining a gonadotropin-releasing hormone agonist (Suprecur, Hoechst, Frankfurt, Germany) with a human menopausal gonadotropin treatment (Gonal F, Serono, Italy or Menogon, Ferring, Kiel, Germany). Follicular development was monitored by ultrasonography and serum E 2 measurements. At an appropriate time in stimulation, 5,000 10,000 IU of hcg (Pregnyl, Organon, Oss, The Netherlands) was administered to induce ovulation. The oocyte retrieval was performed transvaginally using ultrasound. The partner s semen sample was collected through masturbation and ejaculation into a sterile specimen container. According to the sperm count, either a swim-up (IVF) or a mini swim-up technique (severe oligoasthenoteratozoospermia) was performed (17). Fertilization and embryo grade were assessed hours and hours after IVF-ICSI. All embryos were graded according to the method of Veeck (4) at a magnification of 200. Embryos that did not reach four-cell stage on the day of transfer were not considered for transfer. Neither assisted hatching nor cryopreservation was performed. All transfers were performed on day 2 using an Edwards- Wallace Catheter (Smiths Industries, Lancing, Kent, United Kingdom). Three thousand IU of hcg (Pregnyl, Organon, Vienna, Austria) were injected on days 2, 5, and 8 for luteal phase. Seventeen days after intrauterine transfer, blood concentration of hcg was measured. Biochemical pregnancy was defined as a significant increase in hcg levels ( 10 mu/ ml). The implantation rate was defined by ultrasound visualization, 4 weeks after embryo transfer, as a gestional sac per embryo transferred. This included subclinical pregnancies, as evidenced by a gestational sac but no fetal heartbeat, and a clinical pregnancy, evidenced by at least one gestational sac with positive heart activity. If patients did not deliver in our clinic, medical records were requested to get information about birth weight, weeks of gestation, complications during pregnancy (vaginal bleeding, contractions), malformations, and transfer to a neonatal care unit. Statistics The 2 test was used to analyze nominal variables in the form of frequency tables. Normally distributed (Kolmogorov-Smirnov Test with Lilliefors correction) metric variables were tested with the t test for independent samples with correction for heteroscedasticity. Ordinal variables or notnormally distributed metric variables were analyzed with the Mann-Whitney U test. If more than two groups had to be analyzed, normally distributed metric variables (Kolmogorov-Smirnov test with Lilliefors significances) with equal variances (Levene test) were examined by means of one-way ANOVA (multiple comparisons are made with Bonferroni test). For not-normally distributed metric variables or for variables with unequal variances, the Kruskal-Wallis one-way ANOVA was employed (multiple comparisons according to Nemenyi) (18). For correlation analysis, Spearman s rank correlation coefficient was used. All tests were two-tailed with a confidence level of 95% (P.05). No adjustments for the P values (such as Bonferroni-corrections) were made, therefore, all P values are only descriptive. RESULTS Treatment Outcome In 196 transfers, no fragmentation was detectable (group A); in 113 transfers, all embryos showed 25% fragments (group B), 76 revealed 25% 50% fragments (group C), and 75 transfers consisted of poor-quality embryos ( 50% fragments; group D). In Figure 1, these groups data are plotted in terms of the impact of number of embryos on the results of homogeneous transfers (P.001). Including 11 biochemical pregnancies, 175 pregnancies 282 Ebner et al. Embryo fragmentation and its impact on outcome Vol. 76, No. 2, August 2001

3 FIGURE 1 Relationship between number of embryos considered for transfer, embryo fragmentation and clinical pregnancy rate. In 196 transfers, no fragmentation was detectable (group 1; u); in 113 transfers, all embryos showed 25% fragments (group 2; ), 76 revealed 25% 50% fragments (group 3; ), and 75 transfers consisted of poor-quality embryos ( 50% fragments, group 4; s). were recorded. The rates of implantation, clinical pregnancy, and multiple pregnancy are shown in Table 1. In 460 ETs, a total of 1,176 embryos was transferred (mean number, embryos per transfer), of which 198 (16.8%) implanted. A significant influence (at least P.05) of fragmentation on implantation rate and clinical pregnancy rate was detected (Table 1), whereas no difference was seen with regard to multiple pregnancy rate and ongoing pregnancy rate. Pregnancy Outcome Between 1994 and 1999, 144 children were born after homogeneous ET (76 female and 68 male). The sex ratio showed no statistical correlation between the four treatment groups. As shown in Table 2, birth weight and weeks of gestation did not correlate with embryo quality in singleton, twin, and triple pregnancies. The rate of complications and cesarean sections could not be analyzed for multiple pregnancies because of the small numbers in these subgroups. For singleton pregnancies, no significant difference was found in this respect. A total of 41 (28.9%) children had to be admitted to the neonatal care unit. The time of admission to this unit was related to multiple pregnancy but not to embryo quality. Significantly more malformations (P.001) were seen in cohorts with transfer of fragmented embryos (groups C and D). In detail, two cases of trisomy 18, one case of hydrocephalus with an anal atresia, and one case of a hydrocele were diagnosed in group D (36.4%), and in cohort C, one trisomy 21 and one case of fibrome were seen (13.3%). Groups A (cleft lip, ventricular septal defect) and B (oval foramen of heart, hydrocele, encephalic cyst) showed only minor malformations (3.2% and 6.3%, respectively). DISCUSSION The accurate evaluation of embryo implantation potential is crucial during IVF-ET treatment to increase clinical- but not multiple-pregnancy rate. The period before implantation is important for reproductive success because the egg undergoes several cleavage divisions to the blastocyst stage. Implantation itself is a symbiotic interaction between such blastocysts and the endometrium. In the present study, the negative influence of an inadequate endometrium on pregnancy (19) could be minimized by including only women with adequately receptive endometria ( 8 mm). Thus, in the present study, differences in rates of implantation or pregnancy rates may be determined by the number and quality of embryos transferred (1). In fact, though all TABLE 1 Impact of embryo fragmentation on implantation and pregnancy rate. Pregnancy Implantation Study group n PR (%) MPR (%) IR (%) Ongoing (%) A (46.9) a 14 (15.2) 109/508 (21.5) c,d 80 (73.4) B (35.4) b 7 (17.5) 48/297 (16.2) 38 (79.2) C (22.4) 3 (17.7) 21/202 (10.4) 15 (71.4) D (20.0) 5 (25.0) 20/169 (11.8) 11 (55.0) Total (35.7) 29 (17.7) 198/1,176 (16.8) 144 (72.7) Note: IR implantation rate; MPR multiple pregnancy rate; n number of homogeneous transfers; PR clinical pregnancy rate. a P.001 (vs. embryo groups C and D). b P.05 (vs. all other groups). c P.05 (vs. group B). d P.001 (vs. groups C and D). FERTILITY & STERILITY 283

4 TABLE 2 Impact of embryo fragmentation on pregnancy outcome. Study group n Birth weight Week CSR (%) Comp (%) Neo A Singletons 51 3, (19.6) 7 (13.7) 8 3 Twins 14 2, (85.7) 4 (57.1) Triplets 15 1, (100) 1 (20) B Singletons 23 3, (34.8) 6 (26.1) Twins 12 2, (50.0) 1 (16.7) Triplets 3 1, (100) 1 (100) 49 0 C Singletons 11 3, (18.2) 5 (45.5) 4 0 Twins 4 2, (50.0) 1 (50.0) 8 0 D Singletons 9 3, (22.2) 4 (44.4) 23 4 Twins 2 1, (100) 1 (100) Comp complications during pregnancy; CSR cesarean section rate; n number of lifeborn children; Neo staying at neonatology. groups in our investigation had a similar mean number of embryos transferred, the outcome was dependent on the number of embryos transferred per recipient (Fig. 1). Some rapid and less-invasive embryo-grading systems have been evaluated for selecting the optimal embryos for transfer. To date, these systems have been mainly based on size and number of blastomeres as well as on the percentage of anucleate fragments (5, 6, 20, 21). More recently, Alikani et al. (10) suggested including the fragmentation pattern in decision making by retrospectively analyzing large series of cases. Though these authors used a more detailed scale for the degree of fragmentation, our data confirm the results concerning implantation behavior. Because we did not consider fragmentation patterns, our results may be preliminary; nevertheless, for the most part our fragmentation class D corresponded to the type IV pattern previously described by Alikani et al. (10) and, consequently, gave the worst results. There are several mechanisms that are known to cause demise of a high number of preimplantation embryos, including uterine factors, immunological rejection, and chromosomal abnormalities. The fact that embryos with moderate to excessive fragmentation may have limited developmental potential both in vivo and in vitro (22) supports the latter finding. Jurisicova et al. (22) detected a number of morphological features associated with apoptosis (e.g., chromatin condensation, cellular shrinkage) in spare human embryos. In contrast to necrosis, which is triggered by chemical or physical injury, apoptosis is caused by external or internal signals (23). Thus, apoptosis is a deliberate, genetically controlled program and can lead to characteristic cellular fragmentation in human embryos (24). Therefore, embryo fragmentation in transferred embryos may reflect different stages of apoptosis (25). The embryo thus maintaining or restoring its viability (10, 26) may eliminate particular blastomeres being affected by anomalies. Our study confirms previous observations that embryo quality has significant impact on pregnancy rate (2, 5, 6, 10, 26) and, consequently, on implantation rate (3, 5, 28). To our knowledge, this study is the first to indicate that multiple implantation can occur in all fragmentation groups. The implantation potential of bad-quality embryos may be underestimated, though their potential to proceed in development may be limited. To date, differences in fetal loss (clinical abortion rate) among groups with different degrees of fragmentation have not been noted (5, 6, 26); this is probably due to the evaluation of a relative small number of pregnancies resulting from transfer of exclusively bad-quality embryos. However, our analysis of more extensive data confirm that clinical abortion rate does not follow any definite trend. Like biochemical pregnancies (26), clinical abortions may reflect the loss of genetically defective embryos because a higher incidence of a wide range of chromosomal abnormalities (including aneuploidy, polyploidy, mosaicism, and premature chromosome condensation) was found in fragmented embryos (11 13) as compared with embryos without fragments. Controlled hyperstimulation of the ovaries and transfer of more than one viable embryo in infertility treatment has a considerable influence on the incidence of higher-order pregnancies. Multiple gestation is associated with prematurity, low birth weight, and increased perinatal morbidity and mortality. In addition, higher rates of maternal complications may be observed, including threatened miscarriage and pre- 284 Ebner et al. Embryo fragmentation and its impact on outcome Vol. 76, No. 2, August 2001

5 term labor. To minimize the influence of multiple pregnancies on the results of obstetric and perinatal outcome, only singleton pregnancies were compared in the present study. Until now, it has been generally accepted that there is no difference in obstetric and perinatal outcome between IVF- ICSI and natural cycles (14, 15). However, ICSI-IVF pregnancies may show significant differences in birth weight and preterm delivery (29 31) as compared with spontaneously conceived pregnancies. For embryo fragmentation, no correlation could be described in this respect. The rate of cesarean sections, which is thought to be higher in IVF-ICSI than in the general population (30), was not affected by the amount of fragments in the present study, and neither was the rate of complications during pregnancy. Admission to the neonatal care unit did not depend on the degree of fragmentation either. In summary, ongoing pregnancies achieved by transfer of bad-quality embryos (our groups C and D) do not necessarily need to be considered high-risk pregnancies because obstetric outcome (complications, cesarean section rate, preterm delivery) for these pregnancies is comparable to that in groups A and B. Nevertheless, a significantly higher percentage of malformations in newborns derived from heavily fragmented embryos (P.001) requires consultation with the patient before the transfer of such embryos. On the basis of our data and considering the legal restrictions of preimplantation diagnosis in some countries, it may be recommendable to exclude bad-quality embryos from transfer. If the gynecologist has informed the patient about these problems and both have decided together to accept a higher risk of major malformations, either amniocentesis should be considered or the intensity and frequency of ultrasound observations should be increased to minimize perinatal morbidity and mortality. Acknowledgment: The authors are grateful to Joann Hofer-Varela for her editorial advice. References 1. Hsu MI, Mayer J, Aronshon M, Lanzendorf S, Muasher S, Kolm P, et al. Embryo implantation in in vitro fertilization and intracytoplasmic sperm injection: impact of cleavage status morphology grade, and number of embryos transferred. Fertil Steril 1999;72: Erenus M, Zouves C, Rajamahendran P, Leung S, Fluker M, Gomel V. The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization. Fertil Steril 1991;56: Shulman A, Ben-Nun I, Ghetler Y, Kaneti H, Shilon M, Beyth Y. Relationship between embryo morphology and implantation rate after in vitro fertilization treatment in conception cycles. Fertil Steril 1993; 60: Veeck L. Handbook of laboratory diagnosis and treatment infertility. In: Keel BA, Webster RW, eds. Boca Raton, FL: CRC Press, 1990: Staessen C, Camus M, Bollen N, Devroey P, Van Steirteghem A. The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil Steril 1992;57: Giorgetti C, Terriou P, Auquier P, Youve E, Hans E, Spach SL, et al. Embryo score to predict implantation after in-vitro fertilization: based on 957 single embryo transfers. Hum Reprod 1995;10: Claman P, Armant DR, Seibel MM, Wang TA, Oskowitz SP, Taymor ML. The impact of embryo quality and quantity on implantation and the establishment of viable pregnancies. J In Vitro Fert Embryo Transfer 1987;4: Puissant F, Van Rysselberge MV, Barlow P, Deweze J, Leroy E. Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 1987;2: Ziebe S, Petersen K, Lindenberg S, Andersen AG, Gabrielsen A, Andersen AN. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in vitro fertilization. Hum Reprod 1997;12: Alikani M, Cohen J, Tomkin G, Garrisi J, Mack C, Scott RT. Human embryo fragmentation in vitro and its implications for pregnancy and implantation. Fertil Steril 1999;71: Plachot M, Junca AM, Mandelbaum J, de Grouchy J, Salat-Baroux J, Cohen J. Chromosome investigations in early life. Hum Reprod 1987; 1: Munné S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995;64: Munné S, Cohen J. Chromosomal abnormalities in human embryos. Hum Reprod Update 1998;4: Olivennes F, Kadhel P, Rufat P, Fancjin R, Fernandez H, Frydman R. Perinatal outcome of twin pregnancies after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulation. Fertil Steril 1996;66: Manzur A, Goldsman MP, Stone SC, Frederick JL, Balmaceda JP, Asch RH. Outcome of triplet pregnancies after assisted reproductive techniques: how frequent are the vanishing embryos. Fertil Steril 1995;63: Smitz J, Devroey P, Braeckmans P, Camus M, Khan I, Staessen C, et al. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analog and hmg. Hum Reprod 1987;2: Al Hasani S, Kupker W, Baschat AA, Sturm R, Bauer O, Diedrich C. Mini-swim-up: a new technique of sperm preparation for intracytoplasmic sperm injection. J Assist Reprod Genet 1995;12: Nemenyi A. Multiple comparison procedures. In: Hochberg Y, Tamhane A, eds. Probability and mathematical statistics. New York: Wiley Series, 1987: Check JH, Nowroozi K, Choe J, Lurie D, Dietterich C. Influence of endometrial thickness and echo patterns on pregnancy rates during in vitro fertilization. Fertil Steril 1991;56: Steer CV, Mills CL, Tan SL, Campbell S, Edwards RG. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in vitro fertilization end embryo transfer programme. Hum Reprod 1992;7: Hoover L, Baker A, Check JH, Lurie D, O Shaughnessy A. Evaluation of a new embryo-grading system to predict pregnancy rates following in vitro fertilization. Gynecol Obstet Invest 1995;40: Jurisicova A, Varmuza S, Casper RF. Programmed cell death and human embryo fragmentation. Mol Hum Reprod 1996;2: White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: Warner CM, Cao W, Exley GE, McElhinny AS, Alikani M, Cohen J, et al. Genetic regulation of egg and embryo survival. Hum Reprod 1998,13(Suppl 3): Antcak M, Van Blerkom J. Temporal and spatial aspects of fragmentation in early human embryos: possible effects on developmental competence and association with the differential elimination of regulatory proteins from polarized domains. Hum Reprod 1999;14: Visser DS, Fourie FR. The applicability of the cumulative embryo score system for embryo selection and quality control in an in-vitro fertilization/embryo transfer programm. Hum Reprod 1993;8: Hardy K. Cell death in mammalian blastocyst. Mol Hum Reprod 1997;3: Grillo JM, Gamerre M, Lacroix O, Noizet A, Vitry G. Influence of the morphological aspect of embryos obtained by in vitro fertilization on their implantation rate. J In Vitro Fert Embryo Transfer 1991;8: Moise J, Laor A, Armon Y, Gur I, Gale R. The outcome of twin pregnancies after IVF. Hum Reprod 1998;13: Bergh T, Ericson A, Hillensjo T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden : a retrospective cohort study. Lancet 1999;354: Dhont M, De Sutter P, Ruyssink G, Martens G, Bekaert A. Perinatal outcome of pregnancies after assisted reproduction: a case-control study. Am J Obstet Gynecol 1999;181: FERTILITY & STERILITY 285

Human embryo fragmentation in vitro and its implications for pregnancy and implantation

Human embryo fragmentation in vitro and its implications for pregnancy and implantation FERTILITY AND STERILITY VOL. 71, NO. 5, MAY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Human embryo fragmentation

More information

Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine. Volume 72(4) October 1999 pp

Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine. Volume 72(4) October 1999 pp Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine Volume 72(4) October 1999 pp 679-685 Embryo implantation in in vitro fertilization and intracytoplasmic sperm injection:

More information

The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia

The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia FERTILITY AND STERILITY VOL. 72, NO. 4, OCTOBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Embryo implantation

More information

Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles

Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles ORIGINAL ARTICLE Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles Farnaz Sohrabvand 1, Mamak Shariat 2, Navid Fotoohi Ghiam 3, and Mahdi Hashemi

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Abstract. Introduction. Materials and methods. Patients and methods

Abstract. Introduction. Materials and methods. Patients and methods RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos

More information

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

More information

to find a more reliable scoring system to associate embryo morphology and pregnancy outcome.

to find a more reliable scoring system to associate embryo morphology and pregnancy outcome. Embryo quality is more important for younger women whereas age is more important for older women with regard to in vitro fertilization outcome and multiple pregnancy Tsung-Hsien Lee, M.D., M.Sc., a,b,c

More information

Characterization of a top quality embryo, a step towards single-embryo transfer

Characterization of a top quality embryo, a step towards single-embryo transfer Human Reproduction vol.14 no.9 pp.2345 2349, 1999 Characterization of a top quality embryo, a step towards single-embryo transfer Eric Van Royen 1, Katelijne Mangelschots, Diane De Neubourg, Marion Valkenburg,

More information

Article Relationship between even early cleavage and day 2 embryo score and assessment of their predictive value for pregnancy

Article Relationship between even early cleavage and day 2 embryo score and assessment of their predictive value for pregnancy RBMOnline - Vol 14. No 3. 27 294-299 Reproductive BioMedicine Online; www.rbmonline.com/article/2585 on web 22 January 27 Article Relationship between even early cleavage and day 2 embryo score and assessment

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

Study on Several Factors Involved in IVF-ET of Human Beings

Study on Several Factors Involved in IVF-ET of Human Beings Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,

More information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte

More information

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,

More information

Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.

Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.

More information

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

More information

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D. Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006

More information

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline

More information

Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients

Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,

More information

Changes in measured endometrial thickness predict in vitro fertilization success

Changes in measured endometrial thickness predict in vitro fertilization success Changes in measured endometrial thickness predict in vitro fertilization success Grant D. E. McWilliams, D.O., a and John L. Frattarelli, M.D. b a Tripler Army Medical Center, Honolulu, Hawaii; and b Reproductive

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

Articles Follow-up of children born after assisted reproductive technologies

Articles Follow-up of children born after assisted reproductive technologies RBMOnline - Vol 5. No 3. 317 322 Reproductive BioMedicine Online; www.rbmonline.com/article/669 on web 9 August 2002 Articles Follow-up of children born after assisted reproductive technologies Dr Michael

More information

Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers

Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers Received: 22 October 2017 Accepted: 22 January 2018 DOI: 10.1002/rmb2.12090 ORIGINAL ARTICLE Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers

More information

Assisted reproductive technology

Assisted reproductive technology Assisted reproductive technology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Vol. 62, No.4, October 1994 Printed on acid-free paper in U. S. A. Cryopreservation of supernumerary

More information

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic

More information

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Human Reproduction Vol.19, No.11 pp. 2550 2554, 2004 Advance Access publication August 6, 2004 doi:10.1093/humrep/deh447 Should we advise patients undergoing IVF to start a cycle leading to a day 3 or

More information

European IVF Monitoring (EIM) Year: 2013

European IVF Monitoring (EIM) Year: 2013 European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility

More information

Problem Challenge Need. Solution Innovation Invention

Problem Challenge Need. Solution Innovation Invention Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978

More information

Number of oocytes and live births in IVF

Number of oocytes and live births in IVF Number of oocytes and live births in IVF Dr Sesh K Sunkara MD, MRCOG Royal Marsden Hospital, London Kings Healthcare Partners (Guy s & St Thomas NHS Foundation Trust), London, UK Background IVF results

More information

Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos

Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos J. Mamm. Ova Res. Vol. 31 (1), 40 44, 2014 40 Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos Yamato Mizobe*, Toshiaki Akiyoshi, Shiho Minami, Kan Matsuo,

More information

UvA-DARE (Digital Academic Repository) Optimizing the embryo transfer technique Abou-Setta, A.M. Link to publication

UvA-DARE (Digital Academic Repository) Optimizing the embryo transfer technique Abou-Setta, A.M. Link to publication UvA-DARE (Digital Academic Repository) Optimizing the embryo transfer technique Abou-Setta, A.M. Link to publication Citation for published version (APA): Abou-Setta, A. M. (2008). Optimizing the embryo

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

ORIGINAL ARTICLE. Introduction

ORIGINAL ARTICLE. Introduction ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2018;45(3):122-128 Early fragment removal on in vitro fertilization day 2 significantly improves the subsequent development and clinical

More information

Predictive value of embryo grading for embryos with known outcomes

Predictive value of embryo grading for embryos with known outcomes Predictive value of embryo grading for embryos with known outcomes Vanessa N. Weitzman, M.D., Jennifer Schnee-Riesz, M.D., Claudio Benadiva, M.D., John Nulsen, M.D., Linda Siano, M.S., and Donald Maier,

More information

Ovarian response in three consecutive in vitro fertilization cycles

Ovarian response in three consecutive in vitro fertilization cycles FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in

More information

Progesterone and clinical outcomes

Progesterone and clinical outcomes Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER *40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. *40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print

More information

Article Prognosis of oocytes showing aggregation of smooth endoplasmic reticulum

Article Prognosis of oocytes showing aggregation of smooth endoplasmic reticulum RBMOnline - Vol 16 No 1. 2008 113-118 Reproductive BioMedicine Online; www.rbmonline.com/article/3026 on web 15 November 2007 Article Prognosis of oocytes showing aggregation of smooth endoplasmic reticulum

More information

The effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles

The effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of

More information

Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older

Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

IVF Health Risk 503,000 Hit in Google in 0.2 seconds Assisted Reproductive Technologies and Perinatal Morbidity: Interrogating the Association Kurt Barnhart, M.D., MSCE. William Shippen Jr Professor of Obstetrics and Gynecology and Epidemiology Perelman

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Cycle Characteristics of Day 3 Embryo Transfers with 4-Cell Embryos Only

Cycle Characteristics of Day 3 Embryo Transfers with 4-Cell Embryos Only ( C 2003) Cycle Characteristics of Day 3 Embryo Transfers with 4-Cell Embryos Only Assisted Reproduction G. Ertzeid, 1,2 R. Storeng, 1 T. Tanbo, 1 P. O. Dale, 1 S. Bjercke, 1 and T. Åbyholm 1 Submitted

More information

Preimplantation genetic diagnosis: polar body and embryo biopsy

Preimplantation genetic diagnosis: polar body and embryo biopsy Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer

More information

The impact of an assisted conception unit on the workload of a general gynaecology unit

The impact of an assisted conception unit on the workload of a general gynaecology unit BJOG: an International Journal of Obstetrics and Gynaecology February 2002, Vol. 109, pp. 207 211 The impact of an assisted conception unit on the workload of a general gynaecology unit Joanne McManus*,

More information

Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study

Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer

More information

European IVF Monitoring (EIM) Year: 2012

European IVF Monitoring (EIM) Year: 2012 European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone

More information

Hold On To Your Dreams

Hold On To Your Dreams Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create

More information

RBMOnline - Vol 14. No Reproductive BioMedicine Online; on web 23 November 2006

RBMOnline - Vol 14. No Reproductive BioMedicine Online;  on web 23 November 2006 RBMOnline - Vol 14. No 1. 2007 85-91 Reproductive BioMedicine Online; www.rbmonline.com/article/2583 on web 23 November 2006 The value of early cleavage (EC) assessment is still being debated. The aim

More information

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,

More information

Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols*t

Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols*t FERTILITY AND STERILITY Vol. 63, No. I, January 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prospective randomized study on the cryopreservation

More information

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment RBMOnline - Vol 7. No 2. 185 189 Reproductive BioMedicine Online; www.rbmonline.com/article/900 on web 18 June 2003 Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,

More information

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Human Reproduction vol.14 no.1 pp.167 171, 1999 The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Lawrence Engmann 1,2,5, Noreen Maconochie

More information

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,

More information

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol

More information

In Vitro Fertilization What to expect

In Vitro Fertilization What to expect Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,

More information

Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility

Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility Human Reproduction Page 1 of 6 Hum. Reprod. Advance Access published December 9, 2004 doi:10.1093/humrep/deh664 Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor

More information

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra

More information

Predictors of ongoing implantation in IVF in a good prognosis group of patients

Predictors of ongoing implantation in IVF in a good prognosis group of patients Human Reproduction Vol.20, No.7 pp. 1876 1880, 2005 Advance Access publication March 17, 2005 doi:10.1093/humrep/deh872 Predictors of ongoing implantation in IVF in a good prognosis group of patients A.Thurin

More information

International Federation of Fertility Societies. Global Standards of Infertility Care

International Federation of Fertility Societies. Global Standards of Infertility Care International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author

More information

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed

More information

Risk factors for spontaneous abortion in menotropintreated

Risk factors for spontaneous abortion in menotropintreated FERTILITY AND STERILITY Copyright ~ 1987 The American Fertility Society Vol. 48, No. 4, October 1987 Printed in U.S.A. Risk factors for spontaneous abortion in menotropintreated women Michael Bohrer, M.D.*

More information

The Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles

The Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles : 30 1 2003 Kor J Fertil Steril, Vol 30, No 1, 2003, 3 The Comparison of Clinical Outcomes between GnRH Agonist Long Protocol and GnRH Antagonist Short Protocol in Oocyte Donation Cycles Jeong Ho Rhee,

More information

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi

More information

UW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT

UW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT UW MEDICINE PATIENT EDUCATION In Vitro Fertilization How to prepare and what to expect This handout tells how to prepare for and what to expect when you go through a cycle of in vitro fertilization. It

More information

Chromosomal Aneuploidy

Chromosomal Aneuploidy The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common

More information

Age and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine

Age and Fertility. A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine 1 Age and Fertility A Guide for Patients Revised 2012 Copyright 2012 by the American Society for Reproductive Medicine INTRODUCTION Fertility changes with age. Both males and females become fertile in

More information

Dr Manuela Toledo - Procedures in ART -

Dr Manuela Toledo - Procedures in ART - Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic

More information

Pediatrics, Obstetrics and Gynecology, University School of Medicine, Valencia University, Valencia, Spain

Pediatrics, Obstetrics and Gynecology, University School of Medicine, Valencia University, Valencia, Spain Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study María-José Escribá, Ph.D.,

More information

Original Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization

Original Article. KEY WORDS: Doppler, endometrial thickness, in-vitro fertilization Original Article Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hcg by 2D Doppler in in-vitro fertilization cycles: A prospective clinical study from a

More information

A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist

A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist 1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang

More information

Pregnancy outcome and live birth after IVF and ICSI according to embryo quality

Pregnancy outcome and live birth after IVF and ICSI according to embryo quality J Assist Reprod Genet (2007) 24:159 165 DOI 10.1007/s10815-007-9115-z ASSISTED REPRODUCTION Pregnancy outcome and live birth after IVF and ICSI according to embryo quality Patricia Fauque Roger Léandri

More information

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony* aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is

More information

Assisted reproductive technology

Assisted reproductive technology Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo

More information

Articles Does pronuclear morphology and/or early cleavage rate predict embryo implantation potential?

Articles Does pronuclear morphology and/or early cleavage rate predict embryo implantation potential? RBMOnline - Vol 2. No 1. 12 16 Reproductive BioMedicine Online webpaper 2000/039 on web 7/2/01 Articles Does pronuclear morphology and/or early cleavage rate predict embryo implantation potential? Dr Monalill

More information

Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation

Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation Original Article Kisspeptin: A Potential Factor for Unexplained Infertility and Impaired Embryo Implantation Aaida Mumtaz, MBBS. 1#, Aqsa Khalid, MBBS. 1#, Zehra Jamil, M.Phil. 2, Syeda Sadia Fatima, Ph.D.

More information

Outlook Results of assisted reproduction techniques in Latin America*

Outlook Results of assisted reproduction techniques in Latin America* RBMOnline - Vol 2. No 2. 129 137 Reproductive BioMedicine Online webpaper 2000/045 on web 12 Mar 2001 Outlook Results of assisted reproduction techniques in Latin America* Dr Fernando Zegers- Hochschild

More information

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s CLINICAL ASSISTED REPRODUCTION Outcome of IVF in DES-Exposed Daughters: Experience in the 90s LUBNA PAL,1,4 JAN L. SHIFREN,1 KEITH B. ISAACSON,1 YUCHIAO CHANG,2 MARTHA MAREAN,3 LUCY LEYKIN,1 and THOMAS

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Puerto Rico Fertility Center

Puerto Rico Fertility Center Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo

More information

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles r FERTILITY AND STERILITY Copyright ~ 1993 The American Fertility Society Printed on acid-free paper in U.S.A. Complete failure of fertilization in couples with unexplained infertility: implications for

More information

Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS

Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University

More information

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ASRM/SART REGISTRY

More information

IVF Protocols: Hyper & Hypo-Responders, Implantation

IVF Protocols: Hyper & Hypo-Responders, Implantation IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient

More information

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers

More information

0ocyte Related Factors and Chance of Implantation

0ocyte Related Factors and Chance of Implantation Original Article 0ocyte Related Factors and Chance of Implantation Tahereh Madani, M.D. 1*, Mahnaz Ashrafi, M.D. 1, 2, Kiandokht Kiani, M.Sc. 1, Khafri Soraya, M.Sc. 3 1. Endocrinology and Female Infertility

More information

IN VITRO FERTILIZATION

IN VITRO FERTILIZATION FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION

More information